Today's CNBC MarketWrap

Tuesday, Nov. 20, 2007 Today's top 5 stories on CNBC

1. Ditching the Dollar: Now more than ever is the time to sell the dollar, says Jim Rogers, chairman of Beeland Interests. He shares his insight with CNBC's Maria Bartiromo.

2. H&R Block's New Chief: Richard Breeden, a former SEC secretary, is the new CEO of H&R Block. CNBC's Maria Bartiromo asks him about his new role.

3. Drop Dead Freddie: There were big losses at government-sponsored mortgage lender Freddie Mac, and CNBC's Diana Olick has the latest.

4. The Battle Over A-Rod: Warren Buffett appears to have played a role in A-Rod getting back to the Yankees.

5. Fed Minutes Analysis: An analysis of today's Fed minutes, with CNBC's Steve Liesman.

Click here to view all of today's Top stories

Political Capital w/ John Harwood: New Presidential Polls Show Race Is Far From Over CNBC reporter John Harwood blogs on results of the new round of presidential polls that came out this morning and talks about why the primary elections far from over. Click here to view posting.

Tune in to CNBC tomorrow to watch the market unfold

1. Is Countrywide In Trouble? With rumors swirling around its apparent liquidity problems, Countrywide Financial's stock dipped below $10 a share. The fall prompted the company to issue a statement assuring investors about its position. Are there really major problems at the mortgage giant? How much more losses can Countrywide withstand and is CEO Mozilo's job on the line? Jane Wells investigates.

2. Holiday Travel Madness: Phil LeBeau is live at Chicago's O'Hare Intl. Airport taking stock of the holiday travel rush as Americans head to see their relatives for Thanksgiving. Is the stressed air system ready for the bustle or will problems confound travelers?

3. Can Hollywood Bounce Back? Though this year's box office is still running ahead of previous years, we've seen disappointment after disappointment. Even huge stars with huge budgets have had a rough time. This fall, studios are likely to change strategies with a move away from big budget Oscar fare and towards genre movies including horror flicks. What does it mean and what companies stand to profit? Julia Boorstin reports.

4. Pfizer Woes: The FDA issues an early warning about Pfizer's anti-smoking drug Chantix amid reports of suicidal thought among some patients. Mike Huckman examines this warning will likely only add to the woes of the pharmaceutical giant as it sits on its lowest stock price since January of '06.

5. Smoking Out Lung Cancer: Lung cancer kills more people than breast, prostate and colon cancer combined. So why is funding for research so anemic? Survivors say it's all about the stigma. Enter Laura Geller Makeup, one of the largest private cosmetics companies in the U.S, and Joan's Legacy, a lung cancer foundation. They are teaming up to deliver a unique product for an underserved market. The brand new brow brushes are a big hit with survivors and others, giving funding to the foundation and Geller's bottom line. Darby Dunn explains.

CNBC Investing Tools

To unsubscribe to this email click here
If this e-mail was forwarded to you and you would like to subscribe to CNBC's Daily Market Wrap, please click here